CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $509,000 | +10080.0% | 87,212 | +9776.8% | 0.00% | – |
| Q3 2022 | $5,000 | – | 883 | +2107.5% | 0.00% | – |
| Q2 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 40 | -98.2% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 2,253 | -13.8% | 0.00% | – |
| Q1 2021 | $13,000 | -31.6% | 2,613 | +69.6% | 0.00% | – |
| Q4 2020 | $19,000 | – | 1,541 | +3044.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 49 | -25.8% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 66 | -50.0% | 0.00% | – |
| Q1 2020 | $1,000 | -92.3% | 132 | -90.5% | 0.00% | – |
| Q4 2019 | $13,000 | – | 1,394 | +6870.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 20 | -92.4% | 0.00% | – |
| Q3 2018 | $4,000 | -96.9% | 262 | -96.6% | 0.00% | – |
| Q2 2018 | $131,000 | -26.0% | 7,761 | +0.5% | 0.00% | – |
| Q1 2018 | $177,000 | -35.4% | 7,722 | -27.2% | 0.00% | – |
| Q4 2017 | $274,000 | +1041.7% | 10,606 | +542.8% | 0.00% | – |
| Q3 2017 | $24,000 | – | 1,650 | +7073.9% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 23 | -94.0% | 0.00% | – |
| Q1 2017 | $6,000 | -90.3% | 384 | -93.6% | 0.00% | – |
| Q4 2016 | $62,000 | +21.6% | 6,023 | +19.9% | 0.00% | – |
| Q3 2016 | $51,000 | -8.9% | 5,025 | +0.5% | 0.00% | – |
| Q2 2016 | $56,000 | -17.6% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $68,000 | -29.9% | 5,000 | -2.0% | 0.00% | – |
| Q4 2015 | $97,000 | -16.4% | 5,100 | -17.5% | 0.00% | – |
| Q3 2015 | $116,000 | +22.1% | 6,183 | -4.3% | 0.00% | – |
| Q2 2015 | $95,000 | +1087.5% | 6,460 | +1192.0% | 0.00% | – |
| Q1 2015 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | -56.2% | 500 | -61.5% | 0.00% | – |
| Q3 2014 | $16,000 | +433.3% | 1,300 | +333.3% | 0.00% | – |
| Q2 2014 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |